- Home
- TRVI vs NABL Comparison
TRVI vs NABL Comparison
Compare TRVI & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- NABL
- Stock Information
- Founded
- TRVI 2011
- NABL 2000
- Country
- TRVI United States
- NABL United States
- Employees
- TRVI N/A
- NABL N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- NABL Computer Software: Prepackaged Software
- Sector
- TRVI Health Care
- NABL Technology
- Exchange
- TRVI Nasdaq
- NABL Nasdaq
- Market Cap
- TRVI 1.4B
- NABL 1.5B
- IPO Year
- TRVI 2019
- NABL N/A
- Fundamental
- Price
- TRVI $10.91
- NABL $8.41
- Analyst Decision
- TRVI Strong Buy
- NABL Buy
- Analyst Count
- TRVI 9
- NABL 4
- Target Price
- TRVI $20.72
- NABL $9.31
- AVG Volume (30 Days)
- TRVI 1.6M
- NABL 612.6K
- Earning Date
- TRVI 11-10-2025
- NABL 11-06-2025
- Dividend Yield
- TRVI N/A
- NABL N/A
- EPS Growth
- TRVI N/A
- NABL N/A
- EPS
- TRVI N/A
- NABL 0.01
- Revenue
- TRVI N/A
- NABL $482,397,000.00
- Revenue This Year
- TRVI N/A
- NABL $9.79
- Revenue Next Year
- TRVI N/A
- NABL $8.97
- P/E Ratio
- TRVI N/A
- NABL $751.40
- Revenue Growth
- TRVI N/A
- NABL 7.40
- 52 Week Low
- TRVI $2.36
- NABL $6.07
- 52 Week High
- TRVI $11.83
- NABL $13.04
- Technical
- Relative Strength Index (RSI)
- TRVI 55.76
- NABL 62.05
- Support Level
- TRVI $10.22
- NABL $7.56
- Resistance Level
- TRVI $11.82
- NABL $7.88
- Average True Range (ATR)
- TRVI 0.55
- NABL 0.22
- MACD
- TRVI -0.08
- NABL 0.03
- Stochastic Oscillator
- TRVI 30.12
- NABL 82.27
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.